ArticleInfection and drug resistance2024

Applying a Combined Model to Evaluate the Risk of Poor Treatment Outcomes in Rifampicin Resistant Tuberculosis Patients: A Multicenter Retrospective Study.

Yunbin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.